Results 141 to 150 of about 2,081,679 (301)

Toxic shock syndrome other than Streptococcal: (Week 12) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending March 25, 2023

Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Australian and New Zealand Glaucoma Society (ANZGS) Consensus on Interventional Glaucoma

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Traditional reactive ‘wait and see’ approaches in glaucoma management often result in unacceptable rates of permanent vision loss. This consensus defines a proactive ‘interventional glaucoma’ framework tailored for the Australian and New Zealand healthcare context. Methods A modified Delphi consensus process was utilised, consisting
Graham A. Lee, Lance Liu, Ridia Lim, Rajiv Shah, Robert J. Casson, Keith R. Martin, Helen Danesh‐Meyer, Ashish Agar, Jennifer C. Fan Gaskin, Judy Y. Ku, Geoffrey Chan, Anna Galanopoulos, Shamira Perera   +12 more
wiley   +1 more source

Methicillin-resistant Staphylococcus aureus Toxic Shock Syndrome

Emerging Infectious Diseases, 2005
Sophie Jamart, Olivier Denis, Ariane Deplano, Georgios Tragas, Alexandra Vandergheynst, David De Bels, Jacques Devriendt   +6 more
doaj   +1 more source

Strawberry Tongue due to Streptococcal Toxic Shock Syndrome. [PDF]

Clin Case Rep
Takefuji H, Komagamine J, Ota K.
europepmc   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 24) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 1 2023

Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Toxic shock syndrome other than Streptococcal: (Week 33) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 19, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally

core  

Use of Double Dose Intravenous Immunoglobulin Therapy in the Treatment of Streptococcal Toxic Shock Syndrome. [PDF]

Case Rep Crit Care
Xue Y, Yartsev A.
europepmc   +1 more source

Toxic shock syndrome other than Streptococcal: (Week 48) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 2, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Toxic shock syndrome (other than Streptococcal) cases. The Weekly data are considered provisional and collected locally

core  

Effect and length of doxycycline administration in elderly patients with bullous pemphigoid

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease and primarily affects the elderly. Systemic corticosteroids and immunosuppressive drugs are the standard treatment, but side effects often restrict their use. Doxycycline has been proposed as an alternative, but there is limited long‐term, real‐world data on its
Alena Merkel‐Ropele, Wolfgang Salmhofer, Peter Wolf   +2 more
wiley   +1 more source

Fulminant streptococcal toxic shock syndrome presenting as cervical epidural abscess: a case report. [PDF]

J Yeungnam Med Sci
Shin SJ.
europepmc   +1 more source